DNA and RNA Sample Preparation Market Size and Forecast 2032
DNA and RNA Sample Preparation Market By Product Type (Workstations, Kits, Reagents and Consumables); By Application (Clinical Testing, Diagnostic Testing, Research Application, Others); By End-user (Hospitals, Diagnostic Centers, Forensic Science Laboratories, Academic and Research Institutions, Others); By Geography – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
DNA and RNA Sample Preparation Market size was valued at USD 2,210 million in 2024 and is anticipated to reach USD 4,265.72 million by 2032, growing at a CAGR of 8.57% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
DNA and RNA Sample Preparation Market Size 2024
USD 2,210 million
DNA and RNA Sample Preparation Market, CAGR
8.57%
DNA and RNA Sample Preparation Market Size 2032
USD 4,265.72 million
DNA and RNA Sample Preparation Market is led by established life-science and diagnostics companies such as Thermo Fisher Scientific Inc., QIAGEN, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Merck KGaA, Beckman Coulter, Inc., MP Biomedicals, Minerva Biolabs GmbH, Isogen Lifescience B.V., and c-LEcta GmbH, which collectively drive innovation across kits, reagents, consumables, and automated workstations. These players focus on workflow integration, automation, and high-throughput solutions to support PCR and next-generation sequencing applications in clinical and research settings. Regionally, North America dominated the DNA and RNA Sample Preparation Market with 38.6% market share in 2024, supported by strong molecular diagnostics adoption, advanced genomics research infrastructure, and high healthcare spending, followed by Europe and Asia-Pacific with expanding diagnostic and research capabilities.
DNA and RNA Sample Preparation Market Insights
The DNA and RNA Sample Preparation Market was valued at USD 2,210 million in 2024 and is projected to reach USD 4,265.72 million by 2032, growing at a CAGR of 8.57% during the forecast period.
Market growth is driven by expanding molecular diagnostics, rising adoption of PCR and next-generation sequencing, and increasing genomics and life science research across clinical and academic laboratories.
Key market trends include growing automation and high-throughput workflows, with Kits dominating the product segment at 46.3% share in 2024, followed by Reagents and Consumables at 34.8%, while Clinical Testing led applications with 41.7% share.
Strong presence of global players such as Thermo Fisher Scientific Inc., QIAGEN, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., and Merck KGaA supports innovation through advanced kits, reagents, and automated workstations.
Regionally, North America led with 38.6% market share in 2024, followed by Europe at 27.4% and Asia-Pacific at 23.1%, while high system costs and workflow complexity remain key restraints for broader adoption.
DNA and RNA Sample Preparation Market Segmentation Analysis:
By Product Type:
The DNA and RNA Sample Preparation Market by product type is dominated by Kits, which accounted for 46.3% market share in 2024, driven by their standardized protocols, reduced hands-on time, and high reproducibility across clinical and research workflows. Kits enable rapid nucleic acid isolation with consistent yield and purity, supporting large-scale testing and high-throughput sequencing requirements. Reagents and Consumables followed with 34.8% share, supported by recurring demand and routine laboratory usage, while Workstations held 18.9% share, driven by automation adoption in advanced laboratories seeking improved efficiency, contamination control, and workflow scalability.
For instance, QIAGEN’s QIAamp DNA Mini and Blood Mini Kits use silica-membrane spin columns to purify DNA up to 50 kb in about 20–30 minutes per prep, routinely yielding 4–30 µg of DNA suitable for PCR, qPCR, and genotyping applications, with recovery rates above 94% in Midi/Maxi formats.
By Application:
By application, Clinical Testing emerged as the dominant sub-segment, holding 41.7% share in 2024, supported by rising molecular diagnostics adoption, infectious disease screening, and oncology testing. Hospitals and clinical labs increasingly rely on efficient DNA and RNA preparation to ensure diagnostic accuracy and regulatory compliance. Diagnostic Testing accounted for 29.6% share, driven by expanding PCR-based and NGS-based assays. Research Applications represented 22.4% share, supported by genomics, transcriptomics, and biomarker discovery, while Others captured 6.3% share, reflecting niche applications in environmental and agricultural testing.
For instance, Thermo Fisher’s MagMAX Viral/Pathogen II Nucleic Acid Isolation Kit achieved 93.5% concordance with RT-qPCR in testing 278 COVID-19 samples.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
The Academic and Research Institutions segment led the DNA and RNA Sample Preparation Market with 38.9% market share in 2024, driven by sustained funding for genomics research, large-scale sequencing projects, and academic collaborations. Diagnostic Centers followed with 27.5% share, supported by growing demand for molecular diagnostic services and high test volumes. Hospitals accounted for 21.2% share, reflecting increased in-house molecular testing capabilities. Forensic Science Laboratories held 8.1% share, driven by DNA profiling needs, while Others captured 4.3% share, supported by industrial and environmental laboratories.
Key Growth Drivers
Expanding Adoption of Molecular Diagnostics
The DNA and RNA Sample Preparation Market is strongly driven by the expanding adoption of molecular diagnostics across clinical and diagnostic laboratories. Rising prevalence of infectious diseases, genetic disorders, and cancer has increased reliance on PCR, next-generation sequencing, and other nucleic-acid–based tests that require high-quality sample preparation. Accurate isolation and purification of DNA and RNA are critical to ensure diagnostic sensitivity and reproducibility. Growing use of companion diagnostics, personalized medicine, and routine screening programs further accelerates demand for reliable and standardized sample preparation solutions in hospitals, diagnostic centers, and reference laboratories worldwide.
For instance, QIAGEN QIAamp DNA Kits enable rapid purification of high-quality genomic DNA from diverse samples like blood and tissues using spin-column technology, yielding up to 30 µg DNA per preparation with A260/A280 ratios of 1.7-1.9 for PCR and NGS compatibility.
Growth in Genomics and Life Science Research
Rapid growth in genomics, transcriptomics, and biomarker research significantly fuels the DNA and RNA Sample Preparation Market. Academic institutions, research laboratories, and biopharmaceutical companies increasingly conduct large-scale sequencing and gene expression studies, driving demand for efficient and reproducible preparation workflows. High-throughput research projects require consistent nucleic acid yield and purity, increasing dependence on advanced kits, reagents, and automated workstations. Expanding investments in drug discovery, vaccine development, and cell and gene therapy research further strengthen demand for robust DNA and RNA preparation technologies across global research ecosystems.
For instance, QIAGEN’s QIAseq FastSelect –rRNA HMR Kit removes cytoplasmic and mitochondrial rRNA from human, mouse, and rat samples in a single 14-minute inline step compatible with multiple library prep kits.
Rising Automation and High-Throughput Laboratory Demand
Increasing laboratory automation is a key growth driver for the DNA and RNA Sample Preparation Market. Laboratories processing large sample volumes seek automated solutions to minimize manual handling, reduce contamination risks, and improve workflow efficiency. Automated workstations support standardized protocols, faster turnaround times, and scalability, which are essential for clinical testing and centralized diagnostic labs. Growing pressure to improve productivity, reduce operational costs, and address skilled labor shortages encourages laboratories to adopt automated and semi-automated sample preparation platforms, supporting sustained market growth across clinical and research settings.
Key Trends & Opportunities
Integration of Automation with Advanced Technologies
Integration of automation with advanced technologies presents a major trend and opportunity in the DNA and RNA Sample Preparation Market. Manufacturers increasingly develop automated platforms compatible with PCR, NGS, and digital PCR workflows, enabling seamless end-to-end molecular testing. These systems improve reproducibility, reduce error rates, and support high-throughput processing. Opportunities exist in developing compact, flexible platforms tailored for mid-sized laboratories and decentralized testing environments. As laboratories prioritize efficiency and data reliability, demand for integrated and modular sample preparation solutions is expected to expand significantly.
For instance, Tecan’s Freedom EVO NGS workstation automates library preparation for up to 96 samples using just 10 ng of DNA or RNA input, completing the process in less than six hours with precise air displacement pipetting and magnetic bead cleanup.
Expansion in Emerging Markets and Point-of-Care Testing
Emerging markets present significant growth opportunities for the DNA and RNA Sample Preparation Market, driven by improving healthcare infrastructure and expanding molecular diagnostic capabilities. Governments and private players increasingly invest in diagnostic laboratories, research institutions, and public health surveillance programs. Additionally, growing interest in point-of-care and near-patient molecular testing creates opportunities for simplified and rapid sample preparation solutions. Developing user-friendly kits requiring minimal equipment supports adoption in resource-limited settings, expanding market penetration across Asia-Pacific, Latin America, and parts of the Middle East and Africa.
For instance, Takara Bio in Japan scaled production of its RNA extraction kits to meet precision medicine research demands, enabling efficient purification from cells and tissues in expanding academic settings.
Key Challenges
High Cost of Advanced Sample Preparation Solutions
High cost associated with advanced DNA and RNA sample preparation systems remains a major challenge for the market. Automated workstations and premium reagent kits require substantial upfront investment and recurring consumable expenses, limiting adoption among small laboratories and institutions with constrained budgets. Cost sensitivity is particularly pronounced in emerging economies, where laboratories often rely on manual or semi-manual methods. Balancing performance, automation, and affordability remains a critical challenge for manufacturers seeking to expand market reach and ensure broader adoption.
Technical Complexity and Workflow Standardization Issues
Technical complexity and lack of workflow standardization pose challenges in the DNA and RNA Sample Preparation Market. Variability in sample types, extraction methods, and downstream applications can affect nucleic acid quality and experimental outcomes. Laboratories often require customized protocols, increasing training requirements and operational complexity. Inconsistent results across platforms may limit confidence in multi-center studies and diagnostic reproducibility. Addressing these challenges requires continuous innovation in standardized, flexible solutions that maintain performance across diverse applications and laboratory environments.
Regional Analysis
North America
North America led the DNA and RNA Sample Preparation Market with 38.6% market share in 2024, driven by strong adoption of molecular diagnostics, advanced genomics research, and high healthcare spending. The region benefits from a dense presence of biotechnology companies, diagnostic laboratories, and academic research institutions actively utilizing PCR and next-generation sequencing workflows. Widespread automation adoption, early uptake of innovative sample preparation kits, and favorable reimbursement for molecular testing support sustained demand. Continuous investments in precision medicine, oncology diagnostics, and infectious disease testing further strengthen North America’s leadership in the market.
Europe
Europe accounted for 27.4% market share in the DNA and RNA Sample Preparation Market in 2024, supported by expanding molecular diagnostic infrastructure and strong government-backed research initiatives. Countries across Western and Northern Europe demonstrate high utilization of nucleic-acid–based testing in clinical diagnostics and public health surveillance. Growing genomics programs, increasing focus on personalized medicine, and strict regulatory standards drive demand for high-quality and standardized sample preparation solutions. Academic collaborations, rising biopharmaceutical research, and increasing automation in diagnostic laboratories continue to support steady market growth across the European region.
Asia-Pacific
Asia-Pacific captured 23.1% market share in 2024, reflecting rapid expansion of molecular diagnostics and life science research across emerging and developed economies. Rising healthcare investments, increasing prevalence of infectious diseases, and growing adoption of PCR and sequencing technologies drive demand for DNA and RNA sample preparation products. Countries such as China, Japan, India, and South Korea are strengthening diagnostic capabilities and research infrastructure. Expanding biopharmaceutical manufacturing, government-supported genomics initiatives, and growing academic research activity position Asia-Pacific as a high-growth region within the global market.
Latin America
Latin America held 6.2% market share in the DNA and RNA Sample Preparation Market in 2024, driven by gradual improvement in diagnostic infrastructure and increasing awareness of molecular testing. Public and private healthcare providers are expanding PCR-based diagnostics for infectious diseases and genetic testing. Growth in academic research activities and rising collaborations with global biotechnology companies support market development. However, budget constraints and limited automation adoption moderate growth. Increasing government focus on healthcare modernization and expanding laboratory networks continue to create steady demand for cost-effective sample preparation kits and reagents.
Middle East & Africa
The Middle East & Africa region accounted for 4.7% market share in 2024, supported by growing investments in healthcare infrastructure and diagnostic laboratory expansion. Rising focus on infectious disease surveillance, cancer diagnostics, and public health preparedness drives demand for DNA and RNA sample preparation solutions. Gulf countries demonstrate stronger adoption due to advanced healthcare systems, while Africa shows gradual growth supported by international funding and research collaborations. Limited skilled workforce and budget constraints persist, yet increasing molecular diagnostic penetration continues to support long-term market development across the region.
DNA and RNA Sample Preparation Market Segmentations:
By Product Type
Workstations
Kits
Reagents and Consumables
By Application
Clinical Testing
Diagnostic Testing
Research Application
Others
By End-user
Hospitals
Diagnostic Centers
Forensic Science Laboratories
Academic and Research Institutions
Others
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Competitive Landscape
Competitive landscape analysis of the DNA and RNA Sample Preparation Market includes Thermo Fisher Scientific Inc., QIAGEN, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Merck KGaA, Beckman Coulter, Inc., MP Biomedicals, Minerva Biolabs GmbH, Isogen Lifescience B.V., and c-LEcta GmbH. The market is characterized by strong competition driven by product innovation, portfolio expansion, and strategic collaborations. Leading players focus on developing high-performance kits, reagents, and automated workstations to support PCR and next-generation sequencing workflows. Continuous investments in automation, high-throughput solutions, and workflow integration strengthen competitive positioning. Companies actively pursue mergers, partnerships, and geographic expansion to enhance market presence and address rising demand from clinical diagnostics and research applications. Emphasis on reliability, scalability, and regulatory compliance remains critical as laboratories seek standardized and reproducible sample preparation solutions across diverse end-use settings.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In October 2025, QIAGEN launched the EZ2 DNA Investigator SepPrep Kit, an automated solution for sexual assault sample processing that improves sperm DNA recovery and separation from victim DNA in under 2.5 hours on the EZ2 Connect Fx instrument.
In April 2025, QIAGEN launched new QIAseq panels to support comprehensive genomic profiling for research and clinical applications, strengthening its NGS sample preparation portfolio.
In December 2024, Thermo Fisher Scientific launched the MagMAX Sequential DNA and RNA Kit enabling high-quality sequential isolation of genomic DNA and total RNA from a single blood or bone marrow sample to support comprehensive genomic analysis.
Report Coverage
The research report offers an in-depth analysis based on Product Type,Application, End Userand Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
The DNA and RNA Sample Preparation Market is expected to witness sustained growth driven by expanding molecular diagnostics and genomics research activities.
Increasing adoption of next-generation sequencing and PCR-based workflows will continue to strengthen demand for efficient sample preparation solutions.
Automation and high-throughput technologies will gain wider acceptance as laboratories focus on improving productivity and standardization.
Growing emphasis on precision medicine and personalized therapeutics will support long-term demand for high-quality nucleic acid preparation.
Expansion of molecular testing capabilities in emerging economies will broaden the global customer base.
Development of integrated and workflow-compatible platforms will enhance ease of use and reduce operational complexity.
Rising biopharmaceutical research, including cell and gene therapy development, will create new application opportunities.
Simplified and rapid sample preparation kits will support growth in decentralized and near-patient testing environments.
Ongoing innovation in reagents and consumables will improve yield, purity, and reproducibility across applications.
Strategic partnerships and technology advancements will continue to shape competitive dynamics and market evolution.
Table of Contents (The complete Toc, LoF and LoT are available in the sample report)
Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope
Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology
Executive Summary
Introduction
4.1. Overview
4.2. Key Industry Trends
Global DNA and RNA Sample Preparation Market
5.1. Market Overview
5.2. Market Performance
5.3. Impact of COVID-19
5.4. Market Forecast
Market Breakup by Region
9.1. North America
9.1.1. United States
9.1.1.1. Market Trends
9.1.1.2. Market Forecast
9.1.2. Canada
9.1.2.1. Market Trends
9.1.2.2. Market Forecast
9.2. Asia-Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Australia
9.2.6. Indonesia
9.2.7. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Others
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Others
9.5. Middle East and Africa
9.5.1. Market Trends
9.5.2. Market Breakup by Country
9.5.3. Market Forecast
Porters Five Forces Analysis
12.1. Overview
12.2. Bargaining Power of Buyers
12.3. Bargaining Power of Suppliers
12.4. Degree of Competition
12.5. Threat of New Entrants
12.6. Threat of Substitutes
Price Analysis
Competitive Landscape
14.1. Market Structure
14.2. Key Players
14.3. Profiles of Key Players
14.3.1. Minerva Biolabs GmbH
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. Financials
14.3.1.4. SWOT Analysis
14.3.2. Agilent Technologies, Inc.
14.3.3. MP Biomedicals
14.3.4. Beckman Coulter, Inc.
14.3.5. c-LEcta GmbH
14.3.6. Thermo Fisher Scientific Inc.
14.3.7. Isogen Lifescience B.V.
14.3.8. Merck KGaA
14.3.9. Bio-Rad Laboratories, Inc.
14.3.10. QIAGEN
Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the current market size for the DNA and RNA Sample Preparation Market, and what is its projected size in 2032?
The DNA and RNA Sample Preparation Market was valued at USD 2,210 million in 2024 and is projected to reach USD 4,265.72 million by 2032.
At what Compound Annual Growth Rate is the DNA and RNA Sample Preparation Market projected to grow between 2024 and 2032?
The DNA and RNA Sample Preparation Market is projected to grow at a CAGR of 8.57% during the forecast period.
Which DNA and RNA Sample Preparation Market segment held the largest share in 2024?
The Kits segment held the largest share in the DNA and RNA Sample Preparation Market in 2024, accounting for 46.3% of total revenue.
What are the primary factors fueling the growth of the DNA and RNA Sample Preparation Market?
Growth of the DNA and RNA Sample Preparation Market is driven by rising molecular diagnostics adoption, expanding genomics research, and increasing laboratory automation.
Who are the leading companies in the DNA and RNA Sample Preparation Market?
Leading companies in the DNA and RNA Sample Preparation Market include Thermo Fisher Scientific Inc., QIAGEN, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., and Merck KGaA.
Which region commanded the largest share of the DNA and RNA Sample Preparation Market in 2024?
North America commanded the largest share of the DNA and RNA Sample Preparation Market in 2024 with 38.6% market share.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The North America Anti-Infectives Market size was valued at USD 26,431.85 MN in 2021 and reached USD 31,551.94 MN in 2025. It is anticipated to reach USD 43,808.54 MN by 2032, growing at a CAGR of 4.03% during the forecast period.
The glycosaminoglycans (GAGs) market was valued at USD 10,000 million in 2024 and is anticipated to reach USD 19,163.93 million by 2032, registering a CAGR of 8.47% during the forecast period.
The global non-viral drug delivery systems market was valued at USD 15,689 million in 2024 and is projected to reach USD 33,386.1 million by 2032, expanding at a compound annual growth rate (CAGR) of 9.9% during the forecast period 2025-2032.
The DNA Storage for Data Archiving Market size was estimated at USD 1,180.44 million in 2025 and is expected to reach USD 5,279.86 million by 2032, growing at a CAGR of 28.36% from 2025 to 2032.
mRNA Synthesis And Manufacturing Market size was valued USD 1539 million in 2024 and is anticipated to reach USD 1760.73 million by 2032, at a CAGR of 1.7% during the forecast period.
Bioengineered Skin And Skin Substitutes Market size was valued USD 2183 million in 2024 and is anticipated to reach USD 5845.84 million by 2032, at a CAGR of 13.1% during the forecast period.
The Nanobiotechnology Market size was valued at USD 40,210 million in 2024 and is anticipated to reach USD 94891.29 million by 2032, at a CAGR of 11.33 % during the forecast period.
The Pharmaceutical Rapid Microbiology Testing Market size was valued at USD 1,113 million in 2024 and is anticipated to reach USD 3998.75 million by 2032, at a CAGR of 17.34% during the forecast period.
The Essential Thrombocythemia Market size was valued at USD 907.7 million in 2024 and is anticipated to reach USD 1,435.9 million by 2032, at a CAGR of 5.9% during the forecast period.
The global D Dimer Market size was estimated at USD 1,320.92 million in 2025 and is expected to reach USD 1,977.90 million by 2032, growing at a CAGR of 6.96% from 2025 to 2032.
The global Custom Antibody Market size was estimated at USD 630.00 million in 2025 and is expected to reach USD 1,091.95 million by 2032, growing at a CAGR of 9.60% from 2025 to 2032.
The global Culture Media Market size was estimated at USD 4,750.00 million in 2025 and is expected to reach USD 10,176.23 million by 2032, growing at a CAGR of 13.54% from 2025 to 2032.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
